Equities Analysts Offer Predictions for Celsius Q3 Earnings

Key Points

• Roth Capital has lowered its Q3 2025 earnings per share (EPS) estimate for Celsius Holdings Inc. to $0.21, down from $0.22, while maintaining a "Buy" rating and a target price of $70.00.
• Bank of America increased its price target for Celsius to $40.00, while Cowen and Truist Financial reaffirmed their "buy" ratings with target prices of $59.37 and $65.00, respectively.
• Insiders have sold a total of 1,116,141 shares of Celsius stock valued at $52,541,605 in the past three months, indicating potential profit-taking among major shareholders.

Celsius Holdings Inc. (NASDAQ:CELH - Free Report) - Stock analysts at Roth Capital reduced their Q3 2025 earnings per share (EPS) estimates for shares of Celsius in a research report issued on Tuesday, September 2nd. Roth Capital analyst S. Mcgowan now expects that the company will earn $0.21 per share for the quarter, down from their prior forecast of $0.22. Roth Capital currently has a "Buy" rating and a $70.00 target price on the stock. The consensus estimate for Celsius' current full-year earnings is $0.89 per share. Roth Capital also issued estimates for Celsius' Q4 2025 earnings at ($0.44) EPS and Q1 2026 earnings at $0.21 EPS.

A number of other brokerages have also recently weighed in on CELH. Bank of America upped their price target on shares of Celsius from $35.00 to $40.00 and gave the stock an "underperform" rating in a research report on Friday, August 8th. Cowen reaffirmed a "buy" rating on shares of Celsius in a research report on Tuesday. Truist Financial upped their price target on shares of Celsius from $55.00 to $65.00 and gave the stock a "buy" rating in a research report on Monday, August 11th. Citigroup reaffirmed a "buy" rating on shares of Celsius in a research report on Sunday. Finally, Stephens reaffirmed an "overweight" rating on shares of Celsius in a research report on Monday, August 11th. Seventeen research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $59.37.

Celsius Stock Down 0.5%

Shares of Celsius stock opened at $61.10 on Thursday. The company has a fifty day moving average price of $50.76 and a 200 day moving average price of $40.52. The company has a current ratio of 2.11, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. Celsius has a twelve month low of $21.10 and a twelve month high of $63.50. The stock has a market cap of $15.76 billion, a price-to-earnings ratio of 165.14, a price-to-earnings-growth ratio of 1.43 and a beta of 1.34.

Celsius (NASDAQ:CELH - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.47 earnings per share for the quarter, topping analysts' consensus estimates of $0.23 by $0.24. Celsius had a net margin of 7.91% and a return on equity of 36.88%. The firm had revenue of $739.30 million during the quarter, compared to analysts' expectations of $632.13 million. During the same period in the prior year, the company earned $0.28 EPS. The firm's revenue was up 83.9% on a year-over-year basis.

Hedge Funds Weigh In On Celsius

Large investors have recently modified their holdings of the stock. Triumph Capital Management lifted its position in shares of Celsius by 41.5% during the fourth quarter. Triumph Capital Management now owns 40,420 shares of the company's stock worth $1,065,000 after purchasing an additional 11,863 shares during the last quarter. Fifth Third Bancorp lifted its position in shares of Celsius by 62.9% during the first quarter. Fifth Third Bancorp now owns 1,725 shares of the company's stock worth $61,000 after purchasing an additional 666 shares during the last quarter. GAMMA Investing LLC lifted its position in shares of Celsius by 4,164.4% during the first quarter. GAMMA Investing LLC now owns 73,092 shares of the company's stock worth $2,604,000 after purchasing an additional 71,378 shares during the last quarter. Oppenheimer & Co. Inc. lifted its position in shares of Celsius by 14.0% during the first quarter. Oppenheimer & Co. Inc. now owns 9,760 shares of the company's stock worth $348,000 after purchasing an additional 1,199 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. lifted its position in shares of Celsius by 21.4% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 45,517 shares of the company's stock worth $1,621,000 after purchasing an additional 8,009 shares during the last quarter. Institutional investors own 60.95% of the company's stock.

Insiders Place Their Bets

In other news, major shareholder William H. Milmoe sold 100,000 shares of the firm's stock in a transaction dated Thursday, July 31st. The stock was sold at an average price of $47.50, for a total transaction of $4,750,000.00. Following the completion of the sale, the insider directly owned 17,717,770 shares in the company, valued at $841,594,075. This trade represents a 0.56% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder Deborah Desantis sold 100,000 shares of the firm's stock in a transaction dated Thursday, July 31st. The shares were sold at an average price of $47.50, for a total value of $4,750,000.00. Following the sale, the insider owned 17,717,770 shares of the company's stock, valued at $841,594,075. This represents a 0.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 1,116,141 shares of company stock valued at $52,541,605 over the last ninety days. Insiders own 2.20% of the company's stock.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.